Baculoviral COVID-19 Delta DNA vaccine cross-protects against SARS-CoV2 variants in K18-ACE2 transgenic mice

After severe acute respiratory syndrome coronavirus-2 (SARS-CoV2) made the world tremble with a global pandemic, SARS-CoV2 vaccines were developed. However, due to the coronavirus's intrinsic nature, new variants emerged, such as Delta and Omicron, refractory to the vaccines derived using the o...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Yuyeon, Cho, Hansam, Chun, Jungmin, Park, Kihoon, Nowakowska, Aleksandra, Kim, Jinha, Lee, Hyeondong, Lee, Chanyeong, Han, Yejo, Lee, Hee-Jung, Shin, Ha-Youn, Kim, Young Bong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816072/
https://www.ncbi.nlm.nih.gov/pubmed/36631359
http://dx.doi.org/10.1016/j.vaccine.2022.12.067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816072/
https://www.ncbi.nlm.nih.gov/pubmed/36631359
http://dx.doi.org/10.1016/j.vaccine.2022.12.067

Ejemplares similares